Skip to main content

Want a detailed portfolio tracker?

Niagen Bioscience (NAGE) P/E (2011 - 2026)

Niagen Bioscience (NAGE) P/E from Apr 4, 2011 to Jul 21, 2026. The TTM Niagen Bioscience (NAGE) P/E is 14.90. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Niagen Bioscience (NAGE)

YearP/EChange
202614.90-48.65%
202529.02-39.33%
202447.83-389.50%
2023-16.52+194.95%
2022-5.60-40.23%
2021-9.37-67.76%
2020-29.07-16.49%
2019-34.81+25.66%
2018-27.70-41.67%
2017-47.49-13.96%
2016-55.19+38.83%
2015-39.76+135.22%
2014-16.90-73.63%
2013-64.10+1643.07%
2012-3.68-46.95%
2011-6.93N/A

Comparison Niagen Bioscience (NAGE) P/E with competitors

Niagen Bioscience (NAGE) P/E is 14.90.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.99%
NBYStablecoin Development Corp0.00-99.97%
ENLVEnlivex Ltd0.07-99.50%
FGENFibroGen Inc0.24-98.39%
CHRSCoherus Biosciences Inc0.85-94.31%
FBIOFortress Biotech Inc0.95-93.63%
ORMPOramed Pharmaceuticals Inc1.50-89.91%
AGENAgenus Inc3.01-79.80%
INVAInnoviva Inc3.15-78.83%
VXRTVaxart Inc3.55-76.18%
CRMDCorMedix Inc3.63-75.65%
CVACCureVac N.V.4.45-70.17%
GLPGGalapagos NV4.86-67.39%
SRPTSarepta Therapeutics Inc4.88-67.24%
ABEOAbeona Therapeutics Inc5.39-63.84%
ABUSArbutus Biopharma Corp5.60-62.45%
ZVRAZevra Therapeutics Inc5.89-60.49%
SPROSpero Therapeutics Inc6.23-58.20%
CGENCompugen Ltd6.31-57.63%
RIGLRigel Pharmaceuticals6.87-53.88%
SLXNSilexion Therapeutics Corp7.30-51.04%
OMEROmeros Corporation9.26-37.87%
AUPHAurinia Pharmaceuticals Inc9.58-35.68%
PLXProtalix BioTherapeutics Inc10.89-26.91%
ACADAcadia Pharmaceuticals Inc11.73-21.29%
TBPHTheravance Biopharma Inc12.26-17.71%
ADMAAdma Biologics Inc12.42-16.66%
HRMYHarmony Biosciences Holdings Inc13.82-7.25%
SABSSAB Biotherapeutics Inc14.14-5.13%
INCYIncyte Corp15.82+6.18%
REGNRegeneron Pharmaceuticals Inc15.86+6.41%
PBYIPuma Biotechnology Inc17.32+16.20%
CPRXCatalyst Pharmaceuticals Inc17.44+17.03%
EXELExelixis Inc17.54+17.70%
TGTXTG Therapeutics Inc18.97+27.28%
MDXGMimedx Group Inc20.55+37.93%
XOMAXOMA Royalty Corp22.87+53.51%
ARGXArgen X SE24.30+63.07%
CTMXCytomX Therapeutics Inc24.82+66.58%
XOMAOXOMA Royalty Corp25.34+70.09%
HALOHalozyme Therapeutics Inc25.62+71.96%
XOMAPXOMA Royalty Corp25.67+72.27%
VRTXVertex Pharmaceuticals Inc27.99+87.88%
RPRXRoyalty Pharma plc - Class A28.69+92.52%
SLNOSoleno Therapeutics Inc29.02+94.72%
ASNDAscendis Pharma A/S30.09+101.91%
LGNDLigand Pharmaceuticals Inc - Class B37.91+154.43%
APLSApellis Pharmaceuticals Inc39.02+161.88%
BMRNBiomarin Pharmaceutical Inc42.21+183.29%
KRYSKrystal Biotech Inc45.34+204.30%
ONCBeiGene Ltd69.54+366.69%
PHARPharming Group N.V.75.03+403.50%
TECHBio-Techne Corp101.96+584.25%
VCELVericel Corp109.92+637.69%
ALNYAlnylam Pharmaceuticals Inc117.96+691.68%
GMABGenmab140.29+841.51%
TLXTelix Pharmaceuticals Ltd162.15+988.22%
CORTCorcept Therapeutics Inc212.86+1328.51%